Business Today
Subscribe
PMS TodayUS NewsIndiaUPSTARTWeatherBT ShortsNRIEducationElection
BT GolfBT MindrushBT Best Banks
News
markets
stocks
Shree Ganesh Remedies Ltd Partly Paidup
Shree Ganesh Remedies Ltd Partly Paidup

Shree Ganesh Remedies Ltd Partly Paidup Share Price

  • Sector: Pharmaceuticals (Small Cap)
  • Volume: 39
Feb 08, 2024 Closed
  • BSE
Share
  • Whatsapp
  • Twitter
  • Facebook
₹599.95
₹-10.05 (-1.65%)
553.35Low
Today’s Performance
610.00High
-Low
52 Week’s Performance
610.00High

bt_logoStock Performance

  • 1 Day-1.65%
  • 1 Week-0.92%
  • 1 Month7.13%
  • 3 Months38.88%
  • 6 Months89.74%
  • 1 Year364.18%
  • 3 Years-%
  • 5 Years-%

bt_logoStock Summary

  • Face Value (₹)6.00
  • Beta-
  • 52-Week Low (₹)-
  • 52-Week High (₹)-
  • Price-to-Book (X)*0.06
  • Dividend Yield (%)-
  • Price-to-Earnings (P/E) (X)*-
  • Earnings Per Share (₹)-
  • Market Cap (₹ Cr.)*0.63
* Values as of last close price

bt_logoCOMPETITORS

BT TV

Rajiv Memani: China’s Rare Earth Ban a Wake-Up Call for India’s Supply Chain Strategy1:56Rajiv Memani: China’s Rare Earth Ban A Wake-Up Call For India’s Supply Chain Strategy
Nitin Gadkari: 80 Lakh Tonnes of Delhi’s Waste Used for National Road Projects4:33Nitin Gadkari: 80 Lakh Tonnes Of Delhi’s Waste Used For National Road Projects
FSDA Raids Kanwar Route Food Stalls | Live Testing Captured Inside Mobile Lab Van3:56FSDA Raids Kanwar Route Food Stalls | Live Testing Captured Inside Mobile Lab Van
Trump’s Tariff Plan Is Built On Ignorance, Will Harm U.S. Households, Says Journalist David Cay Johnston2:34Trump’s Tariff Plan Is Built On Ignorance, Will Harm U.S. Households, Says Journalist David Cay
Markets Struggle As Trade Talks Loom | Market View With Arun Kejriwal30:40Markets Struggle As Trade Talks Loom | Market View With Arun Kejriwal
“Govt Gone Bankrupt!” Basavaraj Bommai Attacks Congress Over ₹250 Cr Unpaid Dues; Cong Fires Back1:36“Govt Gone Bankrupt!” Basavaraj Bommai Attacks Congress Over ₹250 Cr Unpaid Dues; Cong Fires Back
CII Chief Rajiv Memani Hails PLI Push, Calls for Fixes in Lagging Sectors and State-Level Reforms6:34CII Chief Rajiv Memani Hails PLI Push, Calls For Fixes In Lagging Sectors And State-Level Reforms
Daily Calls LIVE: Ask Your STOCK MARKET TODAY QUERIES | Market Update LIVE | Share Market News Today49:01Daily Calls LIVE: Ask Your STOCK MARKET TODAY QUERIES | Market Update LIVE | Share Market News Today
Trump Ramps Up Tariff Tensions With 14 Countries, Says Deal With India Soon, Keeps Deadline Flexible3:29Trump Ramps Up Tariff Tensions With 14 Countries, Says Deal With India Soon, Keeps Deadline Flexible
SEBI's White Paper On F&O Reveals ₹1 Lakh Average Loss per Retail Trader, Volumes Drop By 26%7:35SEBI's White Paper On F&O Reveals ₹1 Lakh Average Loss Per Retail Trader, Volumes Drop By 26%
View more

bt_logoFAQ's

What was Shree Ganesh Remedies Ltd Partly Paidup share price previously?
Shree Ganesh Remedies Ltd Partly Paidup share price was down by -1.65% from the previous closing price of ₹610.00.
Who are peers of Shree Ganesh Remedies Ltd Partly Paidup?
The peers of Shree Ganesh Remedies Ltd Partly Paidup are Sun Pharmaceutical Industries Ltd, Divis Laboratories Ltd, Cipla Ltd, Torrent Pharmaceuticals Ltd, Dr Reddys Laboratories Ltd, Mankind Pharma Ltd, Zydus Lifesciences Ltd.
Who is/are the promoter/promoters of Shree Ganesh Remedies Ltd Partly Paidup?
The promotor/promotors of Shree Ganesh Remedies Ltd Partly Paidup are
What has been 52-week high of Shree Ganesh Remedies Ltd Partly Paidup stocks?
The highest price of Shree Ganesh Remedies Ltd Partly Paidup stock is ₹0.00 in the last 52-week.
What is the share price of Shree Ganesh Remedies Ltd Partly Paidup (SGRLPP) today on BSE?
As on Feb 08, 2024 Shree Ganesh Remedies Ltd Partly Paidup (SGRLPP)’s share price on BSE is Rs 599.95
What is the market cap of Shree Ganesh Remedies Ltd Partly Paidup (SGRLPP)?
The current market capitalisation of Shree Ganesh Remedies Ltd Partly Paidup (SGRLPP) is 0.63 crores
What is Shree Ganesh Remedies Ltd Partly Paidup Share symbol?
The symbol of Shree Ganesh Remedies Ltd Partly Paidup is .
What is the PE ratio of Shree Ganesh Remedies Ltd Partly Paidup (SGRLPP)?
The current PE ratio of Shree Ganesh Remedies Ltd Partly Paidup (SGRLPP) is -.
What is the PB ratio of Shree Ganesh Remedies Ltd Partly Paidup (SGRLPP)?
The current PB ratio of Shree Ganesh Remedies Ltd Partly Paidup (SGRLPP) is 0.06.
Today’s High & Low share prices of Shree Ganesh Remedies Ltd Partly Paidup (SGRLPP) on BSE?
Today, the share price of Shree Ganesh Remedies Ltd Partly Paidup (SGRLPP) on BSE touched a high of Rs 610 and a low of Rs 553.35
What price did Shree Ganesh Remedies Ltd Partly Paidup (SGRLPP) shares open on the BSE today?
On BSE, the share price of Shree Ganesh Remedies Ltd Partly Paidup (SGRLPP) opened at Rs 610
What is the 52-week high of Shree Ganesh Remedies Ltd Partly Paidup (SGRLPP)?
The 52-week high price of Shree Ganesh Remedies Ltd Partly Paidup (SGRLPP) is Rs 610.00
What is the 52-week low of Shree Ganesh Remedies Ltd Partly Paidup (SGRLPP)?
The 52-week low price of Shree Ganesh Remedies Ltd Partly Paidup (SGRLPP) is Rs -

bt_logoAbout Shree Ganesh PP

Shree Ganesh Remedies Ltd Partly Paidup, incorporated in the year 1995, has its registered office in Plot No 6011, GIDC, Ankleshwar, Gujarat, 393002, 91-2646-227777, 91-2646-226422. The main industry in which Shree Ganesh Remedies Ltd Partly Paidup operates is Pharmaceuticals - Indian - Bulk Drugs & Formln.

Auditor/Auditors for Shree Ganesh Remedies Ltd Partly Paidup is/are . In the main management, is chairman and is the company secretary for Shree Ganesh Remedies Ltd Partly Paidup.

    bt_logoTop Stories

    DATA SOURCES: Corporate data, historical price & volume data published on this website have been sourced from CMOTS Internet Technologies Pvt. Ltd. BSE Quotes and NSE Quotes have been sourced from BSE Limited and NSE Data & Analytics Limited, respectively. All timestamps reflected here are in IST (Indian Standard Time). Stock Analysis section has been sourced from the mentioned partners.

    DISCLAIMER: Any and all content on this website, including the tools/ analysis, is provided to you only for convenience and on an “as-is, as-available” basis without representation and warranties of any kind. The content and any output of such tools/ analysis is for informational purposes only and should not be relied upon or construed as investment advice or guarantee for any specific performance/ returns advice or considered as recommendation for the purchase or sale of any security or investment. You are advised to exercise caution, discretion and independent judgment with regards to the same and seek advice from professionals and certified experts before taking any decisions.

    By using this website, you agree to the Terms of Service and Privacy Policy.